GPC4 and cancer: The downregulation of GPC4 in PCPG and upregulation of GPC4 in CHOL were shown to be approximately log2-fold of −2 and 2, respectively (4-fold change), while in the other above-mentioned cancer types, statistically significant changes ranged between log2-fold of 0.2 and 2 (Figure 1).